The American Society of Clinical Oncology–College of yank Pathologists (ASCO–CAP) guidelines have continued to evolve to Increase the precision and clinical utility of HER2 testing by providing particular algorithms15,16. In parallel with existing strategies, novel techniques to quantify HER2 stages or standardize strategies are being investigated, such as quantitative assays https://www.directivepublications.org/journal-of-clinical-breast-cancer/